These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15014980)

  • 61. Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome.
    Runte M; Varon R; Horn D; Horsthemke B; Buiting K
    Hum Genet; 2005 Feb; 116(3):228-30. PubMed ID: 15565282
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transmission of Angelman syndrome by an affected mother.
    Lossie AC; Driscoll DJ
    Genet Med; 1999; 1(6):262-6. PubMed ID: 11258627
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent assembly of an imprinted domain from non-imprinted components.
    Rapkins RW; Hore T; Smithwick M; Ager E; Pask AJ; Renfree MB; Kohn M; Hameister H; Nicholls RD; Deakin JE; Graves JA
    PLoS Genet; 2006 Oct; 2(10):e182. PubMed ID: 17069464
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
    Low D; Chen KS
    Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 1031-1034delTAAC (Leu125Stop): a novel familial UBE3A mutation causing Angelman syndrome in two siblings showing distinct phenotypes.
    De Molfetta GA; Ferreira CA; Vidal DO; Giuliani Lde R; Maldonado MJ; Silva WA
    BMC Med Genet; 2012 Dec; 13():124. PubMed ID: 23256887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Imprinting regulates mammalian snoRNA-encoding chromatin decondensation and neuronal nucleolar size.
    Leung KN; Vallero RO; DuBose AJ; Resnick JL; LaSalle JM
    Hum Mol Genet; 2009 Nov; 18(22):4227-38. PubMed ID: 19656775
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atypical cases of Angelman syndrome.
    Lawson-Yuen A; Wu BL; Lip V; Sahoo T; Kimonis V
    Am J Med Genet A; 2006 Nov; 140(21):2361-4. PubMed ID: 17036311
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain.
    Bailus BJ; Pyles B; McAlister MM; O'Geen H; Lockwood SH; Adams AN; Nguyen JT; Yu A; Berman RF; Segal DJ
    Mol Ther; 2016 Mar; 24(3):548-55. PubMed ID: 26727042
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model.
    O'Geen H; Beitnere U; Garcia MS; Adhikari A; Cameron DL; Fenton TA; Copping NA; Deng P; Lock S; Halmai JANM; Villegas IJ; Liu J; Wang D; Fink KD; Silverman JL; Segal DJ
    Mol Ther; 2023 Apr; 31(4):1088-1105. PubMed ID: 36641623
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical, cytogenetical and molecular analyses of Angelman syndrome.
    Molfetta GA; Silva WA; Pina-Neto JM
    Genet Couns; 2003; 14(1):45-56. PubMed ID: 12725589
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comprehensive methylation analysis in typical and atypical PWS and AS patients with normal biparental chromosomes 15.
    Runte M; Färber C; Lich C; Zeschnigk M; Buchholz T; Smith A; Van Maldergem L; Bürger J; Muscatelli F; Gillessen-Kaesbach G; Horsthemke B; Buiting K
    Eur J Hum Genet; 2001 Jul; 9(7):519-26. PubMed ID: 11464243
    [TBL] [Abstract][Full Text] [Related]  

  • 72. UBE3A/E6-AP mutations cause Angelman syndrome.
    Kishino T; Lalande M; Wagstaff J
    Nat Genet; 1997 Jan; 15(1):70-3. PubMed ID: 8988171
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Analysis of histone acetylation in genomic imprinting domain of 15q11-q13].
    Okashima M
    Hokkaido Igaku Zasshi; 2004 Jul; 79(4):461-8. PubMed ID: 15373217
    [No Abstract]   [Full Text] [Related]  

  • 74. Double-blind therapeutic trial in Angelman syndrome using betaine and folic acid.
    Peters SU; Bird LM; Kimonis V; Glaze DG; Shinawi LM; Bichell TJ; Barbieri-Welge R; Nespeca M; Anselm I; Waisbren S; Sanborn E; Sun Q; O'Brien WE; Beaudet AL; Bacino CA
    Am J Med Genet A; 2010 Aug; 152A(8):1994-2001. PubMed ID: 20635355
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
    Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
    Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A placebo-controlled trial of folic acid and betaine in identical twins with Angelman syndrome.
    Han J; Bichell TJ; Golden S; Anselm I; Waisbren S; Bacino CA; Peters SU; Bird LM; Kimonis V
    Orphanet J Rare Dis; 2019 Oct; 14(1):232. PubMed ID: 31640736
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A case of an Angelman-syndrome caused by an intragenic duplication of UBE3A uncovered by adaptive nanopore sequencing.
    Holthöfer L; Diederich S; Haug V; Lehmann L; Hewel C; Paul NW; Schweiger S; Gerber S; Linke M
    Clin Epigenetics; 2024 Aug; 16(1):101. PubMed ID: 39095842
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples.
    Scoles HA; Urraca N; Chadwick SW; Reiter LT; Lasalle JM
    Mol Autism; 2011 Dec; 2(1):19. PubMed ID: 22152151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect.
    Neureiter A; Brändl B; Hiber M; Tandon R; Müller FJ; Steenpass L
    Stem Cell Res; 2018 Dec; 33():20-24. PubMed ID: 30296670
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ube3a imprinting impairs circadian robustness in Angelman syndrome models.
    Shi SQ; Bichell TJ; Ihrie RA; Johnson CH
    Curr Biol; 2015 Mar; 25(5):537-45. PubMed ID: 25660546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.